Jennifer A Dantzer1, Robert A Wood2. 1. Division of Pediatric Allergy and Immunology, Department of Pediatrics, John Hopkins University School of Medicine, 600 N. Wolfe St., CMSC 1102, Baltimore, MD, 21287, USA. 2. Division of Pediatric Allergy and Immunology, Department of Pediatrics, John Hopkins University School of Medicine, 600 N. Wolfe St., CMSC 1102, Baltimore, MD, 21287, USA. rwood@jhmi.edu.
Abstract
PURPOSE OF REVIEW: IgE-mediated food allergies are an increasing health concern, and current management includes food avoidance and use of emergency medications. Effective treatment of food allergy is highly desirable. Next generation approaches for the treatment of food allergy aim to improve both safety and efficacy, potentially including long-term tolerance. RECENT FINDINGS: Oral immunotherapy (OIT) and epicutaneous immunotherapy (EPIT) will likely be integrated into clinical practice as part of food allergy management in the near future. Newer approaches, such as sublingual immunotherapy (SLIT), modified proteins, lysosomal-associated membrane protein DNA (LAMP DNA) vaccines, and the use of immunomodulatory agents, are early in development and depending on results, could also become important treatment options. This is a review of novel approaches to the treatment of food allergy that are currently under investigation, including the use of SLIT, modified proteins, probiotics, Chinese herbal supplements, biologic therapies, and DNA vaccines, as well as a summary of the current status of OIT and EPIT.
PURPOSE OF REVIEW: IgE-mediated food allergies are an increasing health concern, and current management includes food avoidance and use of emergency medications. Effective treatment of food allergy is highly desirable. Next generation approaches for the treatment of food allergy aim to improve both safety and efficacy, potentially including long-term tolerance. RECENT FINDINGS: Oral immunotherapy (OIT) and epicutaneous immunotherapy (EPIT) will likely be integrated into clinical practice as part of food allergy management in the near future. Newer approaches, such as sublingual immunotherapy (SLIT), modified proteins, lysosomal-associated membrane protein DNA (LAMP DNA) vaccines, and the use of immunomodulatory agents, are early in development and depending on results, could also become important treatment options. This is a review of novel approaches to the treatment of food allergy that are currently under investigation, including the use of SLIT, modified proteins, probiotics, Chinese herbal supplements, biologic therapies, and DNA vaccines, as well as a summary of the current status of OIT and EPIT.
Authors: Stacie M Jones; A Wesley Burks; Corinne Keet; Brian P Vickery; Amy M Scurlock; Robert A Wood; Andrew H Liu; Scott H Sicherer; Alice K Henning; Robert W Lindblad; Peter Dawson; Cecilia Berin; David M Fleischer; Donald Y M Leung; Marshall Plaut; Hugh A Sampson Journal: J Allergy Clin Immunol Date: 2016-03-09 Impact factor: 10.793
Authors: Giovanni Battista Pajno; Lucia Caminiti; Paolo Ruggeri; Raffaele De Luca; Daniela Vita; Mario La Rosa; Giovanni Passalacqua Journal: Ann Allergy Asthma Immunol Date: 2010-07-31 Impact factor: 6.347
Authors: Stacie M Jones; Wence K Agbotounou; David M Fleischer; A Wesley Burks; Robert D Pesek; Michael W Harris; Laurent Martin; Claude Thebault; Charles Ruban; Pierre-Henri Benhamou Journal: J Allergy Clin Immunol Date: 2016-02-24 Impact factor: 10.793
Authors: Brian P Vickery; Jelena P Berglund; Caitlin M Burk; Jason P Fine; Edwin H Kim; Jung In Kim; Corinne A Keet; Michael Kulis; Kelly G Orgel; Rishu Guo; Pamela H Steele; Yamini V Virkud; Ping Ye; Benjamin L Wright; Robert A Wood; A Wesley Burks Journal: J Allergy Clin Immunol Date: 2016-08-10 Impact factor: 10.793
Authors: Donald Y M Leung; Hugh A Sampson; John W Yunginger; A Wesley Burks; Lynda C Schneider; Cornelis H Wortel; Frances M Davis; John D Hyun; William R Shanahan Journal: N Engl J Med Date: 2003-03-10 Impact factor: 91.245
Authors: B M J Flokstra-de Blok; A E J Dubois; B J Vlieg-Boerstra; J N G Oude Elberink; H Raat; A DunnGalvin; J O'B Hourihane; E J Duiverman Journal: Allergy Date: 2009-10-01 Impact factor: 13.146
Authors: Sandra Andorf; Natasha Purington; Whitney M Block; Andrew J Long; Dana Tupa; Erica Brittain; Amanda Rudman Spergel; Manisha Desai; Stephen J Galli; Kari C Nadeau; R Sharon Chinthrajah Journal: Lancet Gastroenterol Hepatol Date: 2017-12-12
Authors: Laurian Zuidmeer-Jongejan; Hans Huber; Ines Swoboda; Neil Rigby; Serge A Versteeg; Bettina M Jensen; Suzanne Quaak; Jaap H Akkerdaas; Lars Blom; Juan Asturias; Carsten Bindslev-Jensen; Maria L Bernardi; Michael Clausen; Rosa Ferrara; Martina Hauer; Jet Heyse; Stephan Kopp; Marek L Kowalski; Anna Lewandowska-Polak; Birgit Linhart; Bernhard Maderegger; Bernard Maillere; Adriano Mari; Alberto Martinez; E N Clare Mills; Angela Neubauer; Claudio Nicoletti; Nikolaos G Papadopoulos; Antonio Portoles; Ville Ranta-Panula; Sara Santos-Magadan; Heidi J Schnoor; Sigurveig T Sigurdardottir; Per Stahl-Skov; George Stavroulakis; Georg Stegfellner; Sonia Vázquez-Cortés; Marianne Witten; Frank Stolz; Lars K Poulsen; Montserrat Fernandez-Rivas; Rudolf Valenta; Ronald van Ree Journal: Int Arch Allergy Immunol Date: 2015-02-28 Impact factor: 2.749
Authors: Philippe Bégin; Lisa C Winterroth; Tina Dominguez; Shruti P Wilson; Liane Bacal; Anjuli Mehrotra; Bethany Kausch; Anthony Trela; Elisabeth Hoyte; Gerri O'Riordan; Scott Seki; Alanna Blakemore; Margie Woch; Robert G Hamilton; Kari C Nadeau Journal: Allergy Asthma Clin Immunol Date: 2014-01-15 Impact factor: 3.406